GelSana Therapeutics
GelSana Therapeutics is a startup headquartered in Aurora, United States, founded in 2020. It has raised at least $3.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
GelSana Therapeutics has raised at least $3.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
GelSana Therapeutics sits inside the Colorado Front Range R&D ecosystem in the Global R&D Labs Directory.
Other startups in Aurora
- Allander Biotechnologies
- Axis Management Company
- iLumisAR
- Innovative Midfoot Solutions
- Navidence
- OncoVerity
- Pretred
Related
- Innovation profile of Aurora
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does GelSana Therapeutics do?
GelSana Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has GelSana Therapeutics raised?
At least $3.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is GelSana Therapeutics based?
GelSana Therapeutics is headquartered in Aurora, United States.
When was GelSana Therapeutics founded?
GelSana Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.